Low Libido? FDA Weighs Drug to Drive Women’s Desire

In this Friday, Sept. 27, 2013, file photo, a tablet of flibanserin sits on a brochure for Sprout Pharmaceuticals in the company's Raleigh, N.C., headquarters. Sprout Pharmaceuticals, the makers of the twice-rejected pill intended to boost libido in women, will make a third attempt this week at convincing regulators to approve the drug as the first prescription treatment for low sexual desire in women. A panel of FDA experts will discuss the drug at a public meeting Thursday, June 4, 2015 before voting on whether to recommend its approval.(AP Photo/Allen G. Breed, File)
In this Friday, Sept. 27, 2013, file photo, a tablet of flibanserin sits on a brochure for Sprout Pharmaceuticals in the company's Raleigh, N.C., headquarters. The pill has been twice rejected, but Sprout Pharmaceuticals said Tuesday, Feb. 17, 2015, it is refiling its application for flibanserin, adding new information requested by the Food and Drug Administration about how the pill affects driving ability. (AP Photo/Allen G. Breed, File)
In this Friday, Sept. 27, 2013, file photo, a tablet of flibanserin sits on a brochure for Sprout Pharmaceuticals in the company’s Raleigh, N.C., headquarters. (AP Photo/Allen G. Breed, File)

Liz Szabo, USA TODAY

 

WASHINGTON (USA Today) — The drug makers of a  “little pink pill” touted as a boost for female sexual desire will learn its fate Tuesday when the Food and Drug Administration decides whether to approve the drug as a treatment for low libido in women.

Depending on your point of view, the pill, flibanserin — popularly, but incorrectly, dubbed the “female Viagra” — is either the answer to a woman’s prayers or a risky drug that turns a normal condition into a medical problem that only pharmaceuticals can solve. It will be FDA’s third consideration of flibanserin in five years. The agency has twice rejected the drug since 2010.

This time around, the drug benefits from a major public relations push from an advocacy group, Even the Score, which is supported by flibanserin’s manufacturer, Sprout Pharmaceuticals of Raleigh, N.C. High-profile supporters include the National Organization for Women and 11 members of Congress who wrote to the FDA on flibanserin’s behalf.

 

READ MORE

###

1 Trackback / Pingback

  1. Yahabari..South Florida Afro American Aggregated News Portal ! - Low Libido? FDA Weighs Drug to Drive Women’s Desire

Leave a Reply

Your email address will not be published.


*


This site uses Akismet to reduce spam. Learn how your comment data is processed.